Turnstone Biologics Corp.'s total assets for Q3 2024 were $58.48M, a decrease of -23.93% from the previous quarter. TSBX total liabilities were $14.84M for the fiscal quarter, a -13.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.